75 - Stopping the Inevitable? Holistic Approaches to Post-COVID-19 Prevention of Viral Infections in Transplant Patients

Monday, October 20, 2025

1:45 PM - 3:00 PM US ET

Location: B308-B309

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

David Gaston, MD PhD

Assistant Professor, Medical Director (Molecular Infectious Disease Laboratory)
Vanderbilt University Medical Center
Nashville, TN, United States
Christine Johnston, MD, MPH (she/her/hers)

Professor
Medicine
University of Washington
Seattle, WA, United States

Faculty(s)

Erin Gettler, MD (she/her/hers)

Assistant Professor
Department of Medicine, Division of Infectious Diseases
Duke University Hospital
Durham, NC, United States
BT

Ban Hock Tan, MBBS

Senior Consultant
Infectious Diseases
Singapore General Hospital
Singapore, Singapore
William Werbel, MD PhD

Assistant Professor
Johns Hopkins University, MD, United States

Disclosure(s):

David C. Gaston, MD PhD: American Society of Microbiology: Honoraria; Biomerieux/Biofire diagnositcs: Honoraria; DiaSorin: Honoraria; QuidelOrtho: Honoraria; Roche Diagnostics: Honoraria; T2Biosystems: Grant/Research Support

Christine Johnston, MD, MPH: AiCuris.: Advisor/Consultant; Assembly Biosciences: Advisor/Consultant; GSK: Advisor/Consultant, Grant/Research Support; Moderna, Inc.: Grant/Research Support; Oxymo: Advisor/Consultant; Pfizer, Inc.: Advisor/Consultant

Erin Gettler, MD: No financial relationships to disclose.

Ban Hock Tan, MBBS: No financial relationships to disclose.

William Werbel, MD PhD: AstraZenca: Advisor/Consultant

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe heathcare-system wide approaches to respiratory virus prevention for immunocompromised patients;
explain prophylaxis strategies targeting respiratory viruses for immunocompromised patients;
discuss complexities for vaccine-preventable respiratory infections in immunocompromised patients.

Presentations:

1:45 PM - 2:10 PM US ET

Using Real-Time Epidemiology to Inform Infection Prevention
Speaker: Erin Gettler, MD (she/her/hers) – Duke University Hospital
2:10 PM - 2:35 PM US ET

Pre- and Post-Exposure Prophylaxis for Respiratory Viral Infections
Speaker: Ban Hock Tan, MBBS – Singapore General Hospital
2:35 PM - 3:00 PM US ET

The Current Benefits and Unmet Needs of Vaccines Against Respiratory Viral Infections in Transplant Patients
Speaker: William Werbel, MD PhD – Johns Hopkins University